Alx Oncology Holdings (ALXO) — Financial Flexibility Index
Alx Oncology Holdings (ALXO) has a Financial Flexibility Index of -0.45x as of September 2025. Free cash flow of $-17.04 Million (operating CF $-17.09 Million minus capex $56.00K) represents 0% of total liabilities ($37.92 Million). Also explore net asset momentum of Alx Oncology Holdings to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alx Oncology Holdings Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Alx Oncology Holdings across 7 annual periods. Check strategic asset allocation of Alx Oncology Holdings to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Alx Oncology Holdings (2018–2024)
Year-by-year free cash flow to debt coverage for Alx Oncology Holdings . For the full company profile including market capitalisation, see Alx Oncology Holdings stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.56x | $-121.47 Million | $-121.91 Million | $34.16 Million | ▼ -45.6% |
| 2023 | -2.44x | $-129.09 Million | $-130.36 Million | $52.84 Million | ▼ -19.7% |
| 2022 | -2.04x | $-87.80 Million | $-89.22 Million | $43.02 Million | ▲ +44.7% |
| 2021 | -3.69x | $-63.18 Million | $-68.10 Million | $17.13 Million | ▲ +40.2% |
| 2020 | -6.16x | $-38.26 Million | $-38.29 Million | $6.21 Million | ▼ -385.6% |
| 2019 | -1.27x | $-13.90 Million | $-14.25 Million | $10.95 Million | ▲ +79.7% |
| 2018 | -6.24x | $-12.54 Million | $-13.19 Million | $2.01 Million | — |